SynAct Pharma AB (STO:SYNACT)
Sweden
· Delayed Price · Currency is SEK 18.98
-0.04 (-0.21%)
Apr 15, 2025, 2:59 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 934.11 million as of April 15, 2025. Its market cap has increased by 199.09% in one year.
Market Cap
934.11M
Enterprise Value
874.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
18.98
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 934.11M, an increase of 1,365.22%. That is a compound annual growth rate of 35.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 89.78B |
| Getinge AB | 51.65B |
| Sectra AB | 49.09B |
| Camurus AB | 32.96B |
| Medicover AB | 30.18B |
| Vitrolife AB | 21.06B |
| Bonesupport Holding AB | 20.36B |
| Vimian Group AB | 19.86B |